A single-dose, single-period pharmacokinetic assessment of an extended-release orally disintegrating tablet of methylphenidate in children and adolescents with …
A Childress, J Newcorn, JG Stark… - Journal of Child and …, 2016 - liebertpub.com
Objective: To determine the pharmacokinetic (PK) profile of a proprietary formulation of
methylphenidate (MPH) in children and adolescents with attention-deficit/hyperactivity …
methylphenidate (MPH) in children and adolescents with attention-deficit/hyperactivity …
[HTML][HTML] A Single-Dose, Single-Period Pharmacokinetic Assessment of an Extended-Release Orally Disintegrating Tablet of Methylphenidate in Children and …
A Childress, J Newcorn, JG Stark… - Journal of Child and …, 2016 - ncbi.nlm.nih.gov
Objective: To determine the pharmacokinetic (PK) profile of a proprietary formulation of
methylphenidate (MPH) in children and adolescents with attention-deficit/hyperactivity …
methylphenidate (MPH) in children and adolescents with attention-deficit/hyperactivity …
A Single-Dose, Single-Period Pharmacokinetic Assessment of an Extended-Release Orally Disintegrating Tablet of Methylphenidate in Children and Adolescents with …
A Childress, J Newcorn, JG Stark… - Journal of Child and …, 2016 - europepmc.org
Objective To determine the pharmacokinetic (PK) profile of a proprietary formulation of
methylphenidate (MPH) in children and adolescents with attention-deficit/hyperactivity …
methylphenidate (MPH) in children and adolescents with attention-deficit/hyperactivity …
A Single-Dose, Single-Period Pharmacokinetic Assessment of an Extended-Release Orally Disintegrating Tablet of Methylphenidate in Children and Adolescents with …
A Childress, J Newcorn, JG Stark… - Journal of child …, 2016 - pubmed.ncbi.nlm.nih.gov
Objective To determine the pharmacokinetic (PK) profile of a proprietary formulation of
methylphenidate (MPH) in children and adolescents with attention-deficit/hyperactivity …
methylphenidate (MPH) in children and adolescents with attention-deficit/hyperactivity …
[PDF][PDF] A Single-Dose, Single-Period Pharmacokinetic Assessment of an Extended-Release Orally Disintegrating Tablet of Methylphenidate in Children and …
A Childress, J Newcorn, JG Stark… - … OF CHILD AND …, 2016 - pdfs.semanticscholar.org
Objective: To determine the pharmacokinetic (PK) profile of a proprietary formulation of
methylphenidate (MPH) in children and adolescents with attention-deficit/hyperactivity …
methylphenidate (MPH) in children and adolescents with attention-deficit/hyperactivity …
A Single-Dose, Single-Period Pharmacokinetic Assessment of an Extended-Release Orally Disintegrating Tablet of Methylphenidate in Children and Adolescents with …
A Childress, J Newcorn, JG Stark… - Journal of Child and …, 2016 - search.proquest.com
Objective: To determine the pharmacokinetic (PK) profile of a proprietary formulation of
methylphenidate (MPH) in children and adolescents with attention-deficit/hyperactivity …
methylphenidate (MPH) in children and adolescents with attention-deficit/hyperactivity …
A Single-Dose, Single-Period Pharmacokinetic Assessment of an Extended-Release Orally Disintegrating Tablet of Methylphenidate in Children and Adolescents with …
A Childress, J Newcorn, JG Stark… - Journal of Child and …, 2016 - europepmc.org
Objective To determine the pharmacokinetic (PK) profile of a proprietary formulation of
methylphenidate (MPH) in children and adolescents with attention-deficit/hyperactivity …
methylphenidate (MPH) in children and adolescents with attention-deficit/hyperactivity …